MOBIMobia Medical Inc. Common Stock
10.74USD+1.23%Mkt Cap: 352.77M $P/E: —1d ago
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems a…
Industry Peers
Medical Devices$203.22BUSDP/E 37.8
$125.74BUSDP/E 34.0
$118.91BUSDP/E 24.9
$71.03BUSDP/E 19.8
$48.43BUSDP/E 19.9
$52.11BUSDP/E 53.9
$34.85BUSDP/E 36.5
$34.04BUSDP/E 17.2
$25.08BUSDP/E 20.7
$26.90BUSDP/E 20.7
$23.19BUSDP/E 29.1
$19.26BUSDP/E 24.5
$12.75BUSDP/E 79.7
$12.40BUSDP/E 20.1
$11.29BUSDP/E 21.5
$10.95BUSD
$9.84BUSDP/E 20.0
$10.28BUSDP/E 27.5
$10.22BUSDP/E 46.5
$8.82BUSDP/E 25.0
| Headline | Source | Time |
|---|---|---|
Older | ||
 Mobia Medical (MOBI) Q2 2026 Earnings Call Transcript Revenue doubled as Vivistim unit sales and active territories expanded. | ||
Mobia Medical Inc (MOBI) (Q2 2026) Earnings Call Highlights: Revenue Surges 102% as IPO Fuels ... Company reports strong growth in active territories and raises full-year guidance, while net loss widens due to commercial scaling. | ||
 Mobia Medical Q2 Earnings Call Highlights Mobia Medical (NASDAQ:MOBI) reported second-quarter revenue of $13.5 million, up 102% from $6.7 million a year earlier, as adoption of its Vivistim paired vagus nerve stimulation therapy expanded across new and existing stroke-care programs. The company, which completed its initial public offering | ||